Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 5/2011

01-05-2011 | Erratum

Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells

Authors: Shicheng Yang, Luca Gattinoni, Fang Liu, Yun Ji, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan

Published in: Cancer Immunology, Immunotherapy | Issue 5/2011

Login to get access

Excerpt

Unfortunately, in the published article, the second author’s first and last names were interchanged, as Gattinoni Luca. The correct name should be Luca Gattinoni. …
Metadata
Title
Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Authors
Shicheng Yang
Luca Gattinoni
Fang Liu
Yun Ji
Zhiya Yu
Nicholas P. Restifo
Steven A. Rosenberg
Richard A. Morgan
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 5/2011
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-0994-6

Other articles of this Issue 5/2011

Cancer Immunology, Immunotherapy 5/2011 Go to the issue

Original article

Impact of minimal tumor burden on antibody response to vaccination

Original article

Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII

Original Article

CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity

Original article

Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction

Original article

An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity

Original Article

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits